Gentex (GNTX)
NASDAQConsumer DiscretionaryAuto - PartsSnapshot 2026-09-04
$23.14+1.31%
Close 2026-09-04 · 1-day change
NASDAQConsumer DiscretionaryAuto - PartsSnapshot 2026-09-04
QuarterlyIQ Insights · GNTX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $23 GNTX trades at 12× p/e, below its 14× p/e peer median. Our $25 fair value sits above the price. It's a high-confidence read. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $117.85 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $118.97 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $9.46 | — | — | TTM | high |
| graham number | 12M | $23.16 | — | — | TTM | high |
| Peer EV/EBITDA | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $23.14 |
| 7.5 |
| 2.93 |
| TTM |
| high |
| Peer P/FCF | 12M | $34.78 | 14.6 | 2.38 | TTM | high |
| Peer P/E | 12M | $26.53 | 13.5 | 1.96 | TTM | high |
| Peer P/S | 12M | $8.04 | 0.6 | 12.59 | TTM | high |
| PEG | 12M | $33.94 | 17.3 | 1.96 | TTM | high |
| residual income | 12M | $16.25 | — | — | TTM | high |
| Own P/E history | 12M | $26.27 | 13.4 | 1.96 | TTM | high |
| triangulated | 12M | $27.21 | 13.5 | 2.01 | Triangulated | high |
| Peer P/FCF | 3Y | $52.89 | 14.6 | 3.62 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $32.53 | 13.5 | 2.40 | Analyst | medium |
| Peer P/S | 3Y | $9.03 | 0.6 | 14.14 | guidance | medium |
| PEG | 3Y | $41.63 | 17.3 | 2.40 | Analyst | medium |
| Own P/E history | 3Y | $32.22 | 13.4 | 2.40 | Analyst | medium |
| Peer P/FCF | 5Y | $69.95 | 14.6 | 4.79 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $34.38 | 13.5 | 2.54 | Analyst | medium |
| Peer P/S | 5Y | $9.55 | 0.6 | 14.94 | guidance | medium |
| PEG | 5Y | $43.99 | 17.3 | 2.54 | Analyst | medium |
| Own P/E history | 5Y | $34.05 | 13.4 | 2.54 | Analyst | medium |